Characteristics of the 16 Multitransfused Individuals Positive for GBV-C/HGV RNA
Patients . | Sex/Age (yr) in 1996 . | Country of Origin . | Beginning of Transfusions . | HCV Status . | Serological HBV Pattern* . | HIV Status . | Disease . | Follow-up Period . |
---|---|---|---|---|---|---|---|---|
1 | M/20 | Greece | 1977 | + | Vaccinated | + | Thalassemia major | 1988-1996 |
2 | M/19 | Senegal | 1983 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
3 | F/33 | FWI | 1988 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
4 | M/29 | Algeria | 1989 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
5 | M/19 | Mali | 1985 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
6 | F/11 | Lebanon | 1985 | − | Vaccinated | − | Thalassemia major | 1988-1996 |
7 | F/17 | Zaire | 1986 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
8 | M/17 | Algeria | 1982 | − | Vaccinated | − | Thalassemia major | 1992-1996 |
9 | M/5 | France | 1991 | − | Vaccinated | − | Thalassemia major | 1992-1996 |
10 | M/28 | FWI | 1979 | − | Uninfected | − | Sickle cell disease | 1992-1996 |
11 | M/16 | Mali | 1988 | − | Vaccinated | − | Sickle cell disease | 1988-1992† |
12 | F/33 | FWI | 1988 | + | Vaccinated | − | Sickle cell disease | 1992-1996 |
13 | M/14 | Turkey | 1988 | − | Vaccinated | − | Thalassemia major | 1993-1996 |
14 | F/13 | Cameroon | 1986 | − | Vaccinated | − | Sickle cell disease | 1988-1991† |
15 | M/24 | Cameroon | 1984 | + | Infected | − | Sickle cell disease | 1990-1992† |
16 | F/9 | FWI | 1993 | − | Vaccinated | − | Sickle cell disease | 1994-1996 |
Patients . | Sex/Age (yr) in 1996 . | Country of Origin . | Beginning of Transfusions . | HCV Status . | Serological HBV Pattern* . | HIV Status . | Disease . | Follow-up Period . |
---|---|---|---|---|---|---|---|---|
1 | M/20 | Greece | 1977 | + | Vaccinated | + | Thalassemia major | 1988-1996 |
2 | M/19 | Senegal | 1983 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
3 | F/33 | FWI | 1988 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
4 | M/29 | Algeria | 1989 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
5 | M/19 | Mali | 1985 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
6 | F/11 | Lebanon | 1985 | − | Vaccinated | − | Thalassemia major | 1988-1996 |
7 | F/17 | Zaire | 1986 | − | Vaccinated | − | Sickle cell disease | 1988-1996 |
8 | M/17 | Algeria | 1982 | − | Vaccinated | − | Thalassemia major | 1992-1996 |
9 | M/5 | France | 1991 | − | Vaccinated | − | Thalassemia major | 1992-1996 |
10 | M/28 | FWI | 1979 | − | Uninfected | − | Sickle cell disease | 1992-1996 |
11 | M/16 | Mali | 1988 | − | Vaccinated | − | Sickle cell disease | 1988-1992† |
12 | F/33 | FWI | 1988 | + | Vaccinated | − | Sickle cell disease | 1992-1996 |
13 | M/14 | Turkey | 1988 | − | Vaccinated | − | Thalassemia major | 1993-1996 |
14 | F/13 | Cameroon | 1986 | − | Vaccinated | − | Sickle cell disease | 1988-1991† |
15 | M/24 | Cameroon | 1984 | + | Infected | − | Sickle cell disease | 1990-1992† |
16 | F/9 | FWI | 1993 | − | Vaccinated | − | Sickle cell disease | 1994-1996 |